Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionAllianz Asset Management GmbH
Latest Disclosed Ownership1,441,683 shares
Latest Disclosed Value $ 20,846,736
Allianz Asset Management GmbH reports 3.05% decrease in ownership of FOLD / Amicus Therapeutics, Inc.

On May 11, 2026 - Allianz Asset Management GmbH filed a 13F-HR form disclosing ownership of 1,441,683 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $20,846,736 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,486,996 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -3.05% during the quarter. The current value of the position is $20,889,987 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 1,441,683 -45,313 -3.05 20,847 -1.55 0.0082
2026-02-11 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 1,486,996 1,097,887 282.15 21,175 590.61 0.0214
2025-11-04 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 389,109 1,333 0.34 3,066 38.05 0.0034
2025-07-28 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 387,776 16,367 4.41 2,222 -26.70 0.0027
2025-05-05 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 371,409 -4,062 -1.08 3,031 -14.31 0.0040
2025-02-03 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 375,471 65,201 21.01 3,537 6.73 0.0047
2024-11-13 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 310,270 31,159 11.16 3,314 19.69 0.0046
2024-08-13 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 279,111 0 0.00 2,769 -15.79 0.0041
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 279,111 16,779 6.40 3,288 -11.69 0.0051
2024-02-12 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 262,332 7,478 2.93 3,722 20.10 0.0061
2023-11-13 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 254,854 -8,976 -3.40 3,099 -6.46 0.0052
2023-08-14 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 263,830 6,002 2.33 3,314 15.88 0.0059
2023-05-11 2023-03-31 13F AMICUS THERAPEUTICS COM 03152W109 257,828 10,121 4.09 2,859 -5.46 0.0051
2023-02-13 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 247,707 1,433 0.58 3,025 17.62 0.0059
2022-11-08 2022-09-30 13F AMICUS THERAPEUTICS COM 03152W109 246,274 246,274 2,571 0.0052
2021-05-13 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -60,425 -100.00 0 -100.00
2021-02-16 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 60,425 60,425 1,395 0.0014
2020-08-14 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -44,166 -100.00 0 -100.00
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 44,166 -102,071 -69.80 408 -71.35 0.0005
2020-02-13 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 146,237 107,011 272.81 1,424 352.06 0.0013
2019-11-13 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 39,226 537 1.39 315 -34.78 0.0003
2019-08-08 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 38,689 -16,321 -29.67 483 -35.43 0.0004
2019-05-13 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 55,010 23,945 77.08 748 151.01 0.0007
2019-04-02 2018-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 31,065 -166,856 -84.30 298 -87.55 0.0003
2019-02-13 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 31,065 -166,856 298
2019-04-09 2018-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 197,921 -499,969 -71.64 2,393 -78.05 0.0022
2018-11-13 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 197,921 -499,969 2,393
2019-04-09 2018-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 697,890 -95,008 -11.98 10,901 -8.59 0.0106
2018-08-13 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 697,890 -95,008 10,901
2019-04-09 2018-03-31 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 792,898 1,638 0.21 11,925 4.73 0.0114
2018-05-23 2018-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 792,898 0 11,925 0.0114
2018-05-14 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 792,898 1,638 11,925
2019-04-17 2017-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 791,260 36,501 4.84 11,386 0.04 0.0090
2018-02-13 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 791,260 36,501 11,386
2019-04-17 2017-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 754,759 754,759 11,381 0.0099
2017-11-13 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 754,759 754,759 11,381
2017-01-24 2015-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 0 -10,650 -100.00 0 -100.00
2017-01-24 2015-09-30 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 10,650 -3,060 -22.32 149 -23.20 0.0002
2015-11-20 2015-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 10,650 0 149 0.0002
2015-11-13 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 10,650 149
2015-09-22 2015-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 13,710 -10,230 -42.73 194 -25.38 0.0002
2015-08-14 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 13,710 194
2017-01-24 2015-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 23,940 -7,760 -24.48 260 -1.52 0.0003
2015-05-15 2015-03-31 13F AMICUS THERAPEUTICS COM 03152W109 23,940 260,467
2015-02-17 2014-12-31 13F AMICUS THERAPEUTICS COM 03152W109 31,700 -7,490 -19.11 264 13.30 0.0003
2014-11-14 2014-09-30 13F AMICUS THERAPEUTICS COM 03152W109 39,190 39,190 233 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.